Smithfield Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $850K | Buy |
13,520
+8,789
| +186% | +$703K | 0.04% | 188 |
|
|
2025
Q4 | $451K | Sell |
4,731
-383
| -7% | -$37.5K | 0.02% | 249 |
|
|
2025
Q3 | $501K | Sell |
5,114
-1,404
| -22% | -$145K | 0.02% | 232 |
|
|
2025
Q2 | $699K | Sell |
6,518
-100
| -2% | -$10.1K | 0.03% | 183 |
|
|
2025
Q1 | $669K | Sell |
6,618
-186
| -3% | -$18.7K | 0.03% | 194 |
|
|
2024
Q4 | $610K | Hold |
6,804
| – | – | 0.03% | 198 |
|
|
2024
Q3 | $572K | Hold |
6,804
| – | – | 0.03% | 211 |
|
|
2024
Q2 | $523K | Sell |
6,804
-208
| -3% | -$15.2K | 0.03% | 204 |
|
|
2024
Q1 | $481K | Sell |
7,012
-40
| -0.6% | -$2.57K | 0.03% | 211 |
|
|
2023
Q4 | $406K | Sell |
7,052
-1,184
| -14% | -$63.2K | 0.02% | 221 |
|
|
2023
Q3 | $439K | Buy |
8,236
+361
| +5% | +$18.9K | 0.03% | 203 |
|
|
2023
Q2 | $427K | Buy |
7,875
+845
| +12% | +$44.1K | 0.03% | 216 |
|
|
2023
Q1 | $360K | Buy |
7,030
+3,580
| +104% | +$169K | 0.02% | 226 |
|
|
2022
Q4 | $158K | Hold |
3,450
| – | – | 0.01% | 334 |
|
|
2022
Q3 | $132K | Hold |
3,450
| – | – | 0.01% | 340 |
|
|
2022
Q2 | $126K | Sell |
3,450
-590
| -15% | -$24K | 0.01% | 369 |
|
|
2022
Q1 | $177K | Hold |
4,040
| – | – | 0.01% | 331 |
|
|
2021
Q4 | $171K | Hold |
4,040
| – | – | 0.01% | 352 |
|
|
2021
Q3 | $173K | Hold |
4,040
| – | – | 0.01% | 338 |
|
|
2021
Q2 | $173K | Buy |
4,040
+70
| +2% | +$2.94K | 0.01% | 343 |
|
|
2021
Q1 | $154K | Hold |
3,970
| – | – | 0.01% | 363 |
|
|
2020
Q4 | $143K | Sell |
3,970
-380
| -9% | -$13.7K | 0.01% | 362 |
|
|
2020
Q3 | $167K | Buy |
4,350
+430
| +11% | +$16.6K | 0.01% | 310 |
|
|
2020
Q2 | $138K | Buy |
3,920
+3,235
| +472% | +$117K | 0.01% | 332 |
|
|
2020
Q1 | $22K | Sell |
685
-255
| -27% | -$9.96K | ﹤0.01% | 554 |
|
|
2019
Q4 | $42K | Buy |
940
+230
| +32% | +$9.62K | ﹤0.01% | 540 |
|
|
2019
Q3 | $29K | Hold |
710
| – | – | ﹤0.01% | 598 |
|
|
2019
Q2 | $30K | Hold |
710
| – | – | ﹤0.01% | 589 |
|
|
2019
Q1 | $27K | Hold |
710
| – | – | ﹤0.01% | 564 |
|
|
2018
Q4 | $25K | Hold |
710
| – | – | ﹤0.01% | 554 |
|
|
2018
Q3 | $28K | Sell |
710
-30
| -4% | -$1.05K | ﹤0.01% | 607 |
|
|
2018
Q2 | $24K | Buy |
740
+410
| +124% | +$12.4K | ﹤0.01% | 624 |
|
|
2018
Q1 | $9K | Sell |
330
-115
| -26% | -$3.13K | ﹤0.01% | 738 |
|
|
2017
Q4 | $11K | Buy |
+445
| New | +$12.3K | ﹤0.01% | 734 |
|
Other funds holding BSX
VCM
VPM
Smithfield Trust's BSX Position: Q1 2026 in Review
Smithfield Trust increased its Boston Scientific (BSX) stake by 186% in Q1 2026, buying an estimated $703K and bringing the position to 13,520 shares worth $850K. The position accounts for 0.04% of the portfolio, ranked #188.
Smithfield Trust first reported a position in BSX in Q4 2017 and has held it in 34 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Smithfield Trust held 13,520 shares of Boston Scientific worth $850K as of Q1 2026.
- Smithfield Trust bought 8,789 Boston Scientific shares in Q1 2026, an estimated $703K.
- Boston Scientific made up 0.04% of Smithfield Trust's portfolio in Q1 2026, its #188 holding.
- Smithfield Trust first reported a position in Boston Scientific in Q4 2017 and has held it in 34 quarters since.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.